PATIENT-REPORTED OUTCOME (PRO) CLAIMS IN PRODUCTS INDICATED FOR THE TREATMENT OF RARE DISEASES AND APPROVED BY THE EUROPEAN MEDICINES AGENCY (EMA)
Author(s)
Perrier L1, Acquadro C1, Arnould B2
1Mapi Research Trust, Lyon, France, 2Mapi, Lyon, France
Presentation Documents
OBJECTIVES:
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PSY47
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Rare and Orphan Diseases